Finance

Lists
Why is HOWL up 5.71%?
Dive Deeper
HOWL:NASDAQ
Werewolf Therapeutics Inc
$1.11
+5.71%
(+0.060) 1D
Nov 18, 10:21:58 AM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HOWL...
Open
$1.04
High
$1.15
Low
$1.00
Mkt. cap
53.94M
Avg. vol.
400.82K
Volume
427.03K
52-wk high
$1.20
52-wk low
$0.27
EPS
-$0.58
Beta
0.55
Shares outstanding
48.60M
No. of employees
14
Open
$1.04
High
$1.15
Low
$1.00
Mkt. cap
53.94M
Avg. vol.
400.82K
Volume
427.03K
52-wk high
$1.20
52-wk low
$0.27
EPS
-$0.58
Beta
0.55
Shares outstanding
48.60M
No. of employees
14
News stories
From web sources and news partners
About Werewolf Therapeutics Inc
CEO-
Employees14
Founded2017
HeadquartersWatertown, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Analyst
Recommendation
Action
Price target
Projected
Date
Jason Zemansky
Bank of America Securities
Buy
Reiterated
$7.00
+530.6%
02/17/2026
Reni Benjamin
Citizens JMP
Hold
Downgraded
-
-
12/19/2025
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
$4.00
+260.4%
12/19/2025
Last report
Nov 13, 2026
Fiscal period
Q3 2026
-$0.20 / -$0.22
+9.09%beat
Revenue / Est. (USD)
0.00 / 0.00
0.00%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
21.00M
-
Cost of goods sold
6.18M
4.50M
4.64M
-
Cost of revenue
6.18M
4.50M
4.64M
-
Research and development expenses
-
-
-
2.18M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.24M
4.47M
7.82M
7.88M
Operating expense
3.24M
4.47M
7.82M
10.05M
Total operating expenses
9.42M
8.97M
12.46M
10.05M
Operating income
-9.42M
-8.97M
8.54M
-10.05M
Other non operating income
1.84M
674.00K
64.00K
-6.00K
EBT including unusual items
-8.38M
-13.53M
3.67M
-9.88M
EBT excluding unusual items
-8.38M
-9.23M
8.40M
-9.88M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8.38M
-13.53M
3.67M
-9.88M
Net profit margin
-
-
17.48%
-
Earnings per share
-0.17
-0.28
0.14
-0.20
Interest and investment income
564.00K
433.00K
277.00K
183.00K
Interest expense
-1.37M
-1.37M
-475.00K
-
Net interest expenses
-805.00K
-935.00K
-198.00K
183.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.02M
-8.57M
10.99M
-8.79M
Gain or loss from assets sale
-
-
159.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps